Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO for Prevention of AKI in CABG Surgery
NCT00654992Phase 3Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute kidney injury (AKI) comparing EPO group with Placebo group (2 arms). Primary endpoint: Number of Participants Who Had Acute Kidney Injury at 5 days. Started Sep 2006; status: completed.
02
Drugs
epoetin beta
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00654992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654992.